Biotest Diagnostics Corporation appoints Vice President, Transfusion Diagnostics

24-Oct-2006

Biotest diagnostics Corporation (BDC), a subsidiary of Biotest AG, announced the appointment of Candace K. Williams to the newly created position of Vice President of Transfusion Diagnostics. Ms. William's responsibilities will focus on helping BDC strategically position and expand the manual and automated blood group serology business in North America.

Most recently, Ms. Williams has been serving as the Director of Immunohematology Systems for Olympus America. Before joining Olympus, she worked at Parkland Memorial Hospital and University of Texas Health Science Center in Dallas, TX where she obtained her Specialty in Blood Bank certification. She has been active in the American Association of Blood Banks, currently serving as the Chair of the Exhibitor Advisory Committee and as a member of the Educational Advisory Committee.

In her new position at Biotest, Ms. Williams will be responsible for sales, marketing and support of the Biotest Manual Blood Group Serology Reagents and the TANGO Automated Blood Bank System in U.S. hospitals.

Other news from the department people

More news from our other portals

So close that even
molecules turn red...

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 products
1 whitepaper
1 brochures
View topic world
Topic world Diagnostics

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 products
1 whitepaper
1 brochures